Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study of the Xtressé Hair Growth Gummy in Women With Self-Perceived Thinning Hair
NCT07919782 is registered in ClinicalTrials.gov with Restore Biologics Holdings, Inc. dba Xtressé as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Study of the Xtressé Hair Growth Gummy in Women With Self-Perceived Thinning Hair
- Lead sponsor
- Restore Biologics Holdings, Inc. dba Xtressé
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 16, 2026
- Completion date
- November 30, 2027
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
androgenetic alopecia
Arms
As registered; 2 arms.
-
Xtressé Nutraceutical Supplement Active
Xtressé Nutraceutical Supplement 15 participants will be randomized to this group and receive a 90 day supply of the gummy supplement 2 times during the study. Participants will take supplement daily and notate usage in log.
-
Placebo
15 individuals will be randomized to this group and will receive a 90 day supply of the gummy supplement 2 times during the study. Participants will take supplement daily and notate usage in log.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Within-subject increase in hair density assessed via Canfield HairMetrix® Phototrichogram Analysis
Quantitative hair measurements calculated by analyzing the participants digital images from baseline to 6 months of taking Xtressé™ Supplements. Measurements of density as measured hair per cm².
Lead sponsor's other trials
Restore Biologics Holdings, Inc. dba Xtressé, most recent start first.
Similar trials
Same condition (Alopecia) and phase, most recent start first.
+196 more trials See the condition page